PepsiCo (PEP)  said it will buy KeVita, a maker of probiotic and kombucha drinks, to expand its line of health and wellness products.

The price wasn't disclosed. Fortune reported that the transaction will be worth around $200 million. In October, Reuters reported the two companies were close to a deal worth "less than $500 million."

Shares of Pepsi rose 35 cents to $102.61 Tuesday morning after the anouncement.

"KeVita has become an innovative, high-growth brand that is transforming the functional beverage space," PepsiCo Premium Nutrition general manager and VP Chris Lansing said in a statement.

KeVita produces fermented probiotic drinks as well as kombucha, a slightly sparkling black or green tea. The drinks are marketed as organic, non-GMO, gluten free and vegan. Kombucha, which originated in China, has been called an  "immortal health elixir."

PepsiCo said KeVita has a "loyal and rapidly growing consumer base."

The acquisition is subject to federal approval. No further details were immediately available.

Pepsi is a holding in Jim Cramer's Action Alerts PLUS charitable portfolio.

More from Stocks

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

What Will GM Do With Cruise -- and Is Its Stock Worth $55?

What Will GM Do With Cruise -- and Is Its Stock Worth $55?

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

This Should Be Your Retirement Savings Plan When the Stock Market Crashes

This Should Be Your Retirement Savings Plan When the Stock Market Crashes